HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 224 filers reported holding HORIZON PHARMA PLC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $511,000 | -84.0% | 19,350 | -88.1% | 0.02% | -81.9% |
| Q3 2018 | $3,190,000 | +18.2% | 162,900 | 0.0% | 0.12% | +13.7% |
| Q2 2018 | $2,698,000 | +16.6% | 162,900 | 0.0% | 0.10% | +13.3% |
| Q1 2018 | $2,313,000 | -2.7% | 162,900 | 0.0% | 0.09% | -2.2% |
| Q4 2017 | $2,378,000 | +15.1% | 162,900 | 0.0% | 0.09% | +24.3% |
| Q3 2017 | $2,066,000 | +6.8% | 162,900 | 0.0% | 0.07% | +2.8% |
| Q2 2017 | $1,934,000 | -19.7% | 162,900 | 0.0% | 0.07% | -22.6% |
| Q1 2017 | $2,408,000 | -8.6% | 162,900 | 0.0% | 0.09% | -17.0% |
| Q4 2016 | $2,636,000 | -80.6% | 162,900 | -78.3% | 0.11% | -78.6% |
| Q3 2016 | $13,596,000 | +10.1% | 749,900 | 0.0% | 0.52% | +3.8% |
| Q2 2016 | $12,351,000 | -0.6% | 749,900 | 0.0% | 0.50% | -4.5% |
| Q1 2016 | $12,426,000 | -23.5% | 749,900 | 0.0% | 0.53% | -10.4% |
| Q4 2015 | $16,250,000 | +151.6% | 749,900 | +130.2% | 0.59% | +153.9% |
| Q3 2015 | $6,458,000 | – | 325,800 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
| SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
| JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
| Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
| Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
| Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
| Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
| KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |